CYTH - Cyclo Therapeutics, Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Gainesville,
United States
Type: Equity
CYTH price evolution
CYTH
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $9.25 | $1.8 | $0.84 | $0.92 |
| Short term investments | ||||
| Net receivables | $0.12 | $0.3 | $0.09 | $0.13 |
| Inventory | $0.25 | $0.21 | $0.24 | $0.24 |
| Total current assets | $12.32 | $5.51 | $4.55 | $3.99 |
| Long term investments | ||||
| Property, plant & equipment | $0.93 | $0.09 | $0.09 | $0.1 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0.93 | $0.09 | $0.09 | $0.1 |
| Total investments | ||||
| Total assets | $13.25 | $5.6 | $4.64 | $4.1 |
| Current liabilities | ||||
| Accounts payable | $7.46 | $6.6 | $6.08 | $4.48 |
| Deferred revenue | ||||
| Short long term debt | $1.01 | $0.02 | $0.02 | $0.02 |
| Total current liabilities | $8.47 | $6.62 | $6.1 | $4.5 |
| Long term debt | $0.02 | $0.03 | $0.03 | $0.04 |
| Total noncurrent liabilities | $0.02 | $0.03 | $0.03 | $0.04 |
| Total debt | $1.03 | $0.05 | $0.05 | $0.05 |
| Total liabilities | $8.49 | $6.65 | $6.13 | $4.54 |
| Shareholders' equity | ||||
| Retained earnings | -$83.86 | -$78.21 | -$73.44 | -$68.81 |
| Other shareholder equity | ||||
| Total shareholder equity | $4.76 | -$1.05 | -$1.48 | -$0.44 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $9.25 | $1.54 | $16.61 | $12.85 |
| Short term investments | $0.05 | $0.04 | ||
| Net receivables | $0.12 | $0.05 | $0.49 | $0.07 |
| Inventory | $0.25 | $0.25 | $0.23 | $0.24 |
| Total current assets | $12.32 | $4.16 | $19.44 | $14.05 |
| Long term investments | $0.01 | $0.05 | ||
| Property, plant & equipment | $0.93 | $0.06 | $0.08 | $0.09 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0.93 | $0.06 | $0.08 | $0.14 |
| Total investments | $0.05 | $0.09 | ||
| Total assets | $13.25 | $4.22 | $19.52 | $14.19 |
| Current liabilities | ||||
| Accounts payable | $5.77 | $3.48 | $3.68 | $3.54 |
| Deferred revenue | ||||
| Short long term debt | $1.01 | $0.15 | $0.13 | |
| Total current liabilities | $8.47 | $3.48 | $3.83 | $3.67 |
| Long term debt | $0.02 | $0.02 | $0.06 | |
| Total noncurrent liabilities | $0.02 | $0.02 | $0.06 | |
| Total debt | $1.03 | $0.17 | $0.19 | |
| Total liabilities | $8.49 | $3.48 | $3.85 | $3.74 |
| Shareholders' equity | ||||
| Retained earnings | -$83.86 | -$63.8 | -$48.35 | -$34.06 |
| Other shareholder equity | ||||
| Total shareholder equity | $4.76 | $0.73 | $15.67 | $10.45 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.31 | $0.5 | $0.12 | $0.15 |
| Cost of revenue | $0.02 | $0.04 | $0.02 | $0.01 |
| Gross Profit | $0.3 | $0.46 | $0.1 | $0.14 |
| Operating activities | ||||
| Research & development | $4.14 | $3.47 | $3.17 | $3.4 |
| Selling, general & administrative | $1.34 | $1.15 | $1.14 | $1.26 |
| Total operating expenses | $5.94 | $5.22 | $4.73 | $5.15 |
| Operating income | -$5.64 | -$4.77 | -$4.63 | -$5.01 |
| Income from continuing operations | ||||
| EBIT | -$5.64 | -$4.77 | -$4.64 | -$5.01 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$5.64 | -$4.77 | -$4.64 | -$5.01 |
| Income (for common shares) | -$5.64 | -$4.77 | -$4.64 | -$5.01 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1.08 | $1.38 | $1.59 | $0.9 |
| Cost of revenue | $0.08 | $0.14 | $0.16 | $0.07 |
| Gross Profit | $0.99 | $1.24 | $1.43 | $0.84 |
| Operating activities | ||||
| Research & development | $14.18 | $9 | $9.15 | $6.1 |
| Selling, general & administrative | $4.9 | $5.41 | $5.05 | $3.15 |
| Total operating expenses | $21.04 | $16.86 | $15.72 | $9.8 |
| Operating income | -$20.05 | -$15.62 | -$14.29 | -$8.96 |
| Income from continuing operations | ||||
| EBIT | -$20.06 | -$15.45 | -$14.29 | -$8.94 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$20.06 | -$15.45 | -$14.29 | -$8.94 |
| Income (for common shares) | -$20.06 | -$15.45 | -$14.29 | -$8.94 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$5.64 | -$4.77 | -$4.64 | -$5.01 |
| Operating activities | ||||
| Depreciation | $0 | $0 | $0 | $0 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.26 | $0.2 | $0.19 | $0.09 |
| Total cash flows from operations | -$4.29 | -$4.04 | -$3.48 | -$4.37 |
| Investing activities | ||||
| Capital expenditures | -$0 | |||
| Investments | ||||
| Total cash flows from investing | -$0 | |||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.51 | $5 | $2.9 | $1.33 |
| Net borrowings | ||||
| Total cash flows from financing | $11.74 | $5 | $3.41 | $3.74 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $7.44 | $0.96 | -$0.07 | -$0.63 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$20.06 | -$15.45 | -$14.29 | -$8.94 |
| Operating activities | ||||
| Depreciation | $0.02 | $0.02 | $0.02 | $0.01 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.74 | $0.51 | $0.47 | |
| Total cash flows from operations | -$16.19 | -$15.11 | -$15.01 | -$8.54 |
| Investing activities | ||||
| Capital expenditures | -$0 | -$0.02 | -$0.02 | -$0.05 |
| Investments | $0.05 | $0.04 | $0.04 | |
| Total cash flows from investing | -$0 | $0.04 | $0.01 | -$0.01 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $9.74 | $18.76 | $18.46 | |
| Net borrowings | $0.01 | -$0.01 | $0.16 | |
| Total cash flows from financing | $23.89 | $0.01 | $18.76 | $18.62 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $7.7 | -$15.07 | $3.77 | $10.06 |
News
Fundamentals
| Market cap | $34.55M |
|---|---|
| Enterprise value | $26.34M |
| Shares outstanding | 28.56M |
| Revenue | $1.08M |
|---|---|
| EBITDA | -$20.04M |
| EBIT | -$20.06M |
| Net Income | -$20.06M |
| Revenue Q/Q | 66.70% |
| Revenue Y/Y | -21.76% |
| P/E ratio | -1.72 |
|---|---|
| EV/Sales | 24.47 |
| EV/EBITDA | -1.31 |
| EV/EBIT | -1.31 |
| P/S ratio | 32.10 |
| P/B ratio | 7.26 |
| Book/Share | 0.17 |
| Cash/Share | 0.32 |
| EPS | -$0.70 |
|---|---|
| ROA | -290.85% |
| ROE | -4.51K% |
| Debt/Equity | 1.78 |
|---|---|
| Net debt/EBITDA | 0.04 |
| Current ratio | 1.45 |
| Quick ratio | 1.42 |